awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38212007-4F2881BB-189E-4142-92D8-FA1526D1D8EC
Q38212007-4F2881BB-189E-4142-92D8-FA1526D1D8EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38212007-4F2881BB-189E-4142-92D8-FA1526D1D8EC
Canagliflozin: a review of its use in patients with type 2 diabetes mellitus.
P2860
Q38212007-4F2881BB-189E-4142-92D8-FA1526D1D8EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38212007-4F2881BB-189E-4142-92D8-FA1526D1D8EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9833d2ebb875a339a202a4a4d45438469cf96bc5
P2860
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.